Clinical Trials Logo

Stage IA Melanoma clinical trials

View clinical trials related to Stage IA Melanoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT01898403 Active, not recruiting - Stage IV Melanoma Clinical Trials

Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma

Start date: June 2013
Phase: N/A
Study type: Interventional

This clinical trial studies lymph node mapping using indocyanine green solution in diagnosing patients with malignant melanoma. Diagnostic procedures, such as lymph node mapping using indocyanine green solution, may help find out how far the melanoma has spread and may help in planning cancer treatment.

NCT ID: NCT00003895 Completed - Recurrent Melanoma Clinical Trials

Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma

Start date: April 1999
Phase: Phase 2
Study type: Interventional

This randomized pilot phase II trial studies how well vaccine therapy works in treating human leukocyte antigen class 1 histocompatibility, A-2 (HLA-A2) positive patients with melanoma. Vaccines made from peptides may help the body build an effective immune response to kill tumor cells.